Neuren Pharmaceuticals | Gastos De Venta Y Administración



Selling And Administration Expenses Cambio Fecha
Alaunos Therapeutics USD 845K 162K 2024-12
Avita Medical AUD 21.23M 2.57M 2024-12
Clinuvel Pharmaceuticals AUD 16.21M 3.62M 2024-06
Dianthus Therapeutics USD 6.83M 287K 2024-12
Genetic Signatures AUD 10.52M 1.03M 2024-12
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Medical Developments International AUD 12.94M 5.87M 2024-12
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organon & Co USD 453M 33M 2025-06
Paradigm Biopharmaceuticals AUD 2.36M 639.57K 2024-12
PYC Therapeutics AUD 2.58M 1.57M 2024-12
Starpharma Holdings AUD 3.13M 1.31M 2024-12
Tectonic Therapeutic USD 4.84M 469K 2024-12
Telix Pharmaceuticals AUD 87.69M 29.72M 2024-06
Viatris USD 928.7M 111.2M 2025-06
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12


Neuren Pharmaceuticals Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.